Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Asset Utilization Ratio: 2018-2020

Historic Asset Utilization Ratio for Cogent Biosciences (COGT) over the last 3 years, with Sep 2020 value amounting to 0.27.

  • Cogent Biosciences' Asset Utilization Ratio rose 56.44% to 0.27 in Q3 2020 from the same period last year, while for Sep 2020 it was 0.27, marking a year-over-year increase of 56.44%. This contributed to the annual value of 0.05 for FY2020, which is 84.23% down from last year.
  • As of Q3 2020, Cogent Biosciences' Asset Utilization Ratio stood at 0.27, which was down 60.26% from 0.68 recorded in Q2 2020.
  • Over the past 5 years, Cogent Biosciences' Asset Utilization Ratio peaked at 0.68 during Q2 2020, and registered a low of 0.08 during Q3 2018.
  • Over the past 3 years, Cogent Biosciences' median Asset Utilization Ratio value was 0.17 (recorded in 2019), while the average stood at 0.27.
  • Per our database at Business Quant, Cogent Biosciences' Asset Utilization Ratio plummeted by 33.19% in 2019 and then soared by 374.14% in 2020.
  • Quarterly analysis of 3 years shows Cogent Biosciences' Asset Utilization Ratio stood at 0.11 in 2018, then soared by 289.25% to 0.42 in 2019, then spiked by 56.44% to 0.27 in 2020.
  • Its Asset Utilization Ratio was 0.27 in Q3 2020, compared to 0.68 in Q2 2020 and 0.60 in Q1 2020.